On March, 27 is expected Gevo, Inc. (NASDAQ:GEVO)’s earnings report, as reported by Faxor. Analysts forecast $-0.70 EPS, which is $4.50 up or 86.54 % from 2018’s $-5.2 EPS. Wall Street now predicts -17.65 % EPS growth despite Gevo, Inc. last quarter’s EPS of $-0.85. GEVO hit $2.22 during the last trading session after $0.02 change.Currently Gevo, Inc. is downtrending after 75.55% change in last March 7, 2018. GEVO has also 137,110 shares volume. The stock underperformed the S&P500 by 79.92%.

Gevo, Inc., a renewable chemicals and biofuels company, focuses on the development and commercialization of alternatives to petroleum products based on isobutanol produced from renewable feedstocks in the United States.The firm is worth $17.33 million. It operates through two divisions, Gevo, Inc. and Gevo Development/Agri-Energy.Currently it has negative earnings. The firm engages in the research and development, and production of isobutanol; development of its proprietary biocatalysts; production and sale of biojet fuel; and retrofit process of chemicals and biofuels.

For more Gevo, Inc. (NASDAQ:GEVO) news brought out recently go to: Nasdaq.com, Seekingalpha.com, Globenewswire.com, Benzinga.com or Seekingalpha.com. The titles are as follows: “Gevo, Inc. Stock Skyrockets Monday on EPA News – Nasdaq” brought out on June 18, 2018, “APHA, EBAY among premarket gainers – Seeking Alpha” on January 22, 2019, “Gevo to Host Conference Call to Report Third Quarter Financial Results on November 6, 2018 – GlobeNewswire” with a publish date: October 17, 2018, “Gevo (NASDAQ:GEVO) Shares Gain Altitude After Biofuel Demonstration – Benzinga” and the last “The Pain Continues For Gevo’s Shareholders – Seeking Alpha” with publication date: December 31, 2018.